Data / Form D filings / Dare Bioscience, Inc.
Dare Bioscience, Inc.: Form D filings
Dare Bioscience, Inc., a biotechnology company in San Diego, CA, filed 13 Form D notices with the SEC between 2009 and 2026. The latest, on August 20, 2026, reports $12.4 million sold of a $12.4 million offering to 12 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3655 NOBEL DRIVE SUITE 260, San Diego, CA, 92122
- Phone
- (858) 926-7655
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1401914
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 20, 2026 | New notice | $12,375,054 | $12,375,054 | 12 | Aug 17, 2026 | sec.gov | |
| Nov 22, 2024 | New notice | $15,000,000 | $0 | $15,000,000 | 1 | Oct 21, 2024 | sec.gov |
| Dec 26, 2023 | New notice | $4,160,400 | $1,733,500 | $2,426,900 | 1 | Dec 21, 2023 | sec.gov |
| Sep 7, 2021 | Amendment | $3,544,992 | $3,544,992 | 28 | Nov 20, 2019 | sec.gov | |
| Dec 6, 2019 | New notice | $2,369,992 | $2,369,992 | 28 | Nov 20, 2019 | sec.gov | |
| Jul 28, 2017 | New notice | $20,691,388 | $20,691,388 | 18 | Jul 19, 2017 | sec.gov | |
| Oct 17, 2016 | New notice | $1 | $1 | 1 | Oct 4, 2016 | sec.gov | |
| Dec 14, 2012 | New notice | $13,000,000 | $13,000,000 | 16 | Nov 30, 2012 | sec.gov | |
| Dec 15, 2011 | New notice | $15,000,098 | $15,000,098 | 19 | Dec 2, 2011 | sec.gov | |
| Nov 19, 2010 | New notice | $23,999,989 | $16,499,994 | $7,499,995 | 17 | Nov 12, 2010 | sec.gov |
| Oct 13, 2010 | New notice | $1,499,999 | $1,499,999 | 15 | Sep 29, 2010 | sec.gov | |
| Jun 9, 2010 | New notice | $5,000,000 | $5,000,000 | 13 | May 26, 2010 | sec.gov | |
| Jul 27, 2009 | New notice | $10,000,000 | $10,000,000 | 13 | Jul 13, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Sabrina Martucci Johnson | Executive Officer, Director | President and Chief Executive Officer |
| MarDee Haring-Layton | Executive Officer | Chief Accounting Officer |
| William H. Rastetter | Director | |
| Jessica D. Grossman | Director | |
| Susan L. Kelley | Director | |
| Gregory W. Matz | Director | |
| Robin J. Steele | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Aug 17, 2026 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Dare Bioscience, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.